Related Experiment Video
Updated: Apr 20, 2026

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
Published on: February 24, 2026
Long-acting injectable antipsychotics: an underutilized treatment option
1Technische Universitaet Muenchen, Psychiatry, Moehlstrasse 26, Muenchen, Bavaria 81675, Germany s.heres@lrz.tu-muenchen.de.
Aripiprazole long-acting injection (LAI) effectively treated acute schizophrenia episodes over 10 weeks. Patients showed improved psychopathology and functioning with good safety, making it a viable treatment option.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Schizophrenia is a severe mental disorder impacting psychopathology and functioning.
- Acute episodes require effective and safe treatment interventions.
Purpose of the Study:
- To evaluate the efficacy and safety of aripiprazole long-acting injection (LAI) for acute schizophrenia episodes.
Main Methods:
- A randomized controlled trial comparing aripiprazole LAI to placebo.
- Assessment of psychopathology and functioning at 10 weeks.
Main Results:
- Aripiprazole LAI demonstrated significant improvements in psychopathology compared to placebo.
- Patients receiving aripiprazole LAI also showed enhanced functioning.
- The treatment exhibited an acceptable tolerability and safety profile.
Conclusions:
- Aripiprazole LAI is an effective treatment for acute schizophrenia episodes.
- The medication offers a viable therapeutic option with a favorable safety profile.
More Related Videos
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Drug Therapy
Antianxiety Medications
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Antipsychotic Drugs: Typical and Atypical Agents
Antidepressant Drugs: MAOIs and Other Agents

